| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 05/06/2005 | WO2005040154A1 Novel imidazole derivatives and their use as pharmaceutical agents |
| 05/06/2005 | WO2005040153A1 Novel triarylimidazoles |
| 05/06/2005 | WO2005040152A1 Heteroyclylphenyl-and heterocyclylpyridyl-substituted azolecarboxamides as herbicides |
| 05/06/2005 | WO2005040151A1 Pyrazine derivatives and pharmaceutical use thereof |
| 05/06/2005 | WO2005040150A2 Glutamine fructose-6-phosphate amidotransferase (gfat) inhibitors |
| 05/06/2005 | WO2005040144A1 Novel compounds |
| 05/06/2005 | WO2005040137A1 Aminoalkyl-pyrazinones and -pyridones as thrombin inhibitors |
| 05/06/2005 | WO2005040136A1 Piperazine derivatives and their use as modulators of nuclear hormone receptor function |
| 05/06/2005 | WO2005040133A1 Pyrimidine compounds for the treatment of inflammation |
| 05/06/2005 | WO2005040132A1 Dicationic triaryl analogs as anti-protozoan agents |
| 05/06/2005 | WO2005040131A1 1,5,7-trisubstituted benzimidazole derivatives and their use for modulating the gabaa receptor complex |
| 05/06/2005 | WO2005040129A2 Ccr3 receptor antagonists |
| 05/06/2005 | WO2005040128A1 Heterocyclyl compounds |
| 05/06/2005 | WO2005040121A2 Amides that inhibit vanilloid receptor subtype 1 (vr1) receptor |
| 05/06/2005 | WO2005040119A1 Tetrahydro-naphthalene and urea derivatives |
| 05/06/2005 | WO2005040116A2 Indolinone derivatives and their use in treating disease-states such as cancer |
| 05/06/2005 | WO2005040114A1 Compounds having crth2 antagonist activity |
| 05/06/2005 | WO2005040110A1 Pyrrole and pyrazole derivatives as potentiators of glutamate receptors |
| 05/06/2005 | WO2005040109A1 Ligands of melanocortin receptors and compositions and methods related thereto |
| 05/06/2005 | WO2005040108A1 Prolinamide derivatives as sodium and/or calcium channel blockers or selective mao-b inhibitors |
| 05/06/2005 | WO2005039569A1 5-substituted 2-(phenylmethyl) thio-4-phenyl-4h-1,2,4-triazole derivatives and related compounds as gaba-agonists for the treatment of urinary incontinence and related diseases |
| 05/06/2005 | WO2005039564A1 Phthalimide compounds useful as protein kinase inhibitors |
| 05/06/2005 | WO2005030753A3 Therapeutic agents useful for treating pain |
| 05/06/2005 | WO2005028443A3 Protein tyrosine kinase enzyme inhibitors |
| 05/06/2005 | WO2005005395A3 Arylamine-substituted quinazolinone compounds |
| 05/06/2005 | WO2005004818A3 Heterocyclic compounds and their use as anticancer agents |
| 05/06/2005 | WO2004043928A8 N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobial agents |
| 05/06/2005 | CA2543644A1 Pyrazine derivatives and pharmaceutical use thereof |
| 05/06/2005 | CA2543419A1 Ccr3 receptor antagonists |
| 05/06/2005 | CA2543079A1 Dicationic triaryl analogs as anti-protozoan agents |
| 05/06/2005 | CA2542716A1 Compounds having crth2 antagonist activity |
| 05/06/2005 | CA2542682A1 5-substituted 2-(phenylmethyl) thio-4-phenyl-4h-1,2,4-triazole derivatives and related compounds as gaba-agonists for the treatment of urinary incontinence and related diseases |
| 05/06/2005 | CA2542514A1 Pyrimidine compounds for the treatment of inflammation |
| 05/06/2005 | CA2542064A1 Tao kinase modulators and methods of use |
| 05/06/2005 | CA2541690A1 Glutamine fructose-6-phosphate amidotransferase (gfat) inhibitors |
| 05/06/2005 | CA2541460A1 Indolinone derivatives and their use in treating disease-states such as cancer |
| 05/06/2005 | CA2540765A1 Pyrimidin-2-amine derivatives and their use as a2b adenosine receptor antagonists |
| 05/06/2005 | CA2539967A1 Amides that inhibit vanilloid receptor subtype 1 (vr1) receptor |
| 05/06/2005 | CA2538134A1 Novel imidazole derivatives and their use as pharmaceutical agents |
| 05/06/2005 | CA2538131A1 Novel triarylimidazoles |
| 05/05/2005 | US20050096478 Derivatives of fluoro(hydro)carbons attached to an -alkylene-oxy-carbonyl-leaving group; reactive with amine-containing compounds to form a fluoro-substituted carbamyl protective group useful for the efficient separation, recovery and purification of synthsized organic compounds; libraries |
| 05/05/2005 | US20050096470 novel intermediate (5-substituted) (6-substituted) 6H-imidazo[4,5-c]tetrazolo[1,5-a]quinoline compounds of given formula; intermediate to antiviral immunomodulator 1H-imidazo[4,5-c]quinolin-4-amines |
| 05/05/2005 | US20050096468 Inhibitors of histone deacetylase |
| 05/05/2005 | US20050096377 Substituted sulfonamide-indoles |
| 05/05/2005 | US20050096368 Heterocyclo-substituted imidazoles for the treatment of inflammation |
| 05/05/2005 | US20050096359 melanocortin receptor agonist, antagonist; preventing or treating inflammatory diseases, AIDS, obesity, bulimia, anorexia or sexual dysfunction; N-(2-aminoethyl)-3'-[1-{N-(1-benzylpiperidin-4-yl)-N-(2-naphthylacetyl)aminoethyl][1,1'-biphenyl)-2-carboxamide dihydrochloride |
| 05/05/2005 | US20050096357 Antibiotics; therapy for infections which is caused by drug-resistant Streptococcus, or bacteria infections |
| 05/05/2005 | US20050096354 Process for the preparation of substituted aryl pyrazoles |
| 05/05/2005 | US20050096353 Indolyl and dihydroindolyl derivatives, their manufacture and use as pharmaceutical agents |
| 05/05/2005 | US20050096352 Process for the preparation of pantoprazole and salts thereof |
| 05/05/2005 | US20050096351 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 05/05/2005 | US20050096348 non-insulin dependent diabetes mellitus, and impaired glucose tolerance; dipeptidyl peptidase IV (DPP-IV) inhibitors eg (2S)-1-{[(1S)-2-(5-cyano-2-methyl-indol-1-yl)-1-methyl-ethylamino]-acetyl}-pyrrolidine-2-carbonitrile |
| 05/05/2005 | US20050096344 controlling signal transduction; anticancer agents; antitumor agents; angiogenesis inhibitors; atherosclerosis; vision defects; antidiabetic agents; antiinflammatory agents; antiischemic agents |
| 05/05/2005 | US20050096327 eg 2-(4-Methyl-piperazin-1-yl)-4-phenyl-quinazoline; attention deficit hyperactivity disorder |
| 05/05/2005 | US20050096325 use of specified inhibitors of chemokine receptors to treat inflammatory diseases such as asthma, allergic rhinitis, atopic dermatitis, inflammatory bowel diseases, idiopathic pulmonary fibrosis, bullous pemphigoid, allergic colitis, eczema, conjunctivitis, familial eosinophilia |
| 05/05/2005 | US20050096316 Quinoline derivatives(2) |
| 05/05/2005 | US20050096313 Substance P; 2-(phenyl)-4-(3-oxo-piperazin-1-yl-)-piperidine-1-carboxylic acid; benzyl-methylamide; antagonists of the NK1 receptor; antidepressant, antiolytic; antiemetic |
| 05/05/2005 | US20050096312 Antiserotonine agents; antidepressants; eating disorders; anxiolytic agents; sleep disorders; gastrointestinal disorders; cardiovascular disorders; muscular disorders; endocrine system diseases; muscular disorders; psychological disorders |
| 05/05/2005 | US20050096309 For use as anticoagulant agents for therapy of thromboembolic disorders |
| 05/05/2005 | US20050096297 Antibacterial agents |
| 05/05/2005 | US20050096278 Antibacterial agents |
| 05/05/2005 | US20050096253 Utilization of inhibitors of rho-kinases for stimulating nerve growth, inhibiting scar tissue formation and/or reducing a secondary lesion |
| 05/05/2005 | US20050092452 Such as 1-butyl-3-hydroxy-1-[2-hydroxy-3-(1-oxyl-2,2,6,6-tetramethyl-piperidin-4-yloxy)-propyl]-azetidinium chloride; yellowing and discoloration prevention; ultraviolet, fluorescent and solar light stability; expanding use of high yield pulps to higher grade products |
| 05/04/2005 | EP1528061A1 Heterocyclic derivatives which inhibit factor Xa |
| 05/04/2005 | EP1527345A2 Method for isolating atp binding proteins by means of immobilized protein inhibitors |
| 05/04/2005 | EP1527069A2 Pyridines and pyrimidines substituted by 4-trifluoromethylpyrazolyl |
| 05/04/2005 | EP1527067A1 4-trifluoromethylpyrazolyl substituted pyridines and pyrimidines |
| 05/04/2005 | EP1527066A1 Salt of (s)-pantoprazole and its hydrates |
| 05/04/2005 | EP1527051A1 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 05/04/2005 | EP1527050A1 Quinoline derivatives and their use as mycobacterial inhibitors |
| 05/04/2005 | EP1527049A2 Fused heterocyclic compounds as peptidase inhibitors |
| 05/04/2005 | EP1527046A1 Indoline derivatives substituted in position 6, production and use thereof as medicaments |
| 05/04/2005 | EP1526895A2 Methods for treating carbonic anhydrase mediated disorders |
| 05/04/2005 | EP1526869A1 Compositions of a cyclooxygenase-2 selective inhibitor and a carbonic anhydrase inhibitor for the treatment of neoplasia |
| 05/04/2005 | EP1526854A1 4-4(methylpiperazin-1-ylmethyl)-n- 4-methyl-3-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl -benzamide for treating mutated-ret kinase associated diseases |
| 05/04/2005 | EP1526851A2 Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy |
| 05/04/2005 | EP1448553B1 N-heterocyclyl hydrazides as neurotrophic agents |
| 05/04/2005 | EP1317448B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/04/2005 | EP1242061B1 Use of bioactive metabolites of gepirone for the manufacture of a medicament for the treatment of psychological disorders |
| 05/04/2005 | EP1147103B1 Phenantrhridine-n-oxides with pde-iv inhibiting activity |
| 05/04/2005 | EP1140830B1 Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine amide derivatives having 5ht1a receptor activity |
| 05/04/2005 | EP1139752B1 Methods and compositions for treatment of cell proliferative disorders |
| 05/04/2005 | EP1127057B1 Naphthyridine compounds and thier azaisosteric analogues as antibacterials |
| 05/04/2005 | EP1119567B1 Quinazoline derivatives |
| 05/04/2005 | EP0886637B9 Inhibitors of microsomal triglyceride transfer protein and method |
| 05/04/2005 | EP0815099B1 Tricyclic amide compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 05/04/2005 | CN1612865A Triazole derivatives as cyclooxygenase (COX) inhibitors |
| 05/04/2005 | CN1612864A Novel alkansulfonamides as endothelin antagonists |
| 05/04/2005 | CN1612861A Ecl labels having improved non-specific binding properties, methods of using and kits containing the same |
| 05/04/2005 | CN1612763A Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
| 05/04/2005 | CN1612735A Uses for anti-malarial therapeutic agents |
| 05/04/2005 | CN1612734A Aqueous liquid preparations and light-stabilized aqueous liquid preparations |
| 05/04/2005 | CN1612733A Benzimidazoles useful as protein kinase inhibitors |
| 05/04/2005 | CN1612732A Analgesics and methods of use |
| 05/04/2005 | CN1611499A Heterocyclic compounds as inhibitors of rotamase enzymes |
| 05/04/2005 | CN1199968C New desloratadine salts, process for their synthesis and pharmaceutical compositions thereof |
| 05/04/2005 | CN1199954C Benzodiazepine derivatives |
| 05/04/2005 | CN1199948C Pyridine derivatives, its preparing process and use as berbicide intemrediate |
| 05/04/2005 | CN1199947C Process for production of pyridine derive |
| 05/03/2005 | US6888020 Water-soluble dithioesters and method for polymerization thereof |